![Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival](https://epivax.com/wp-content/uploads/2021/05/Ancer-Figure-for-website-Publication-1080x675.png)
![Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival](https://epivax.com/wp-content/uploads/2021/05/Ancer-Figure-for-website-Publication-1080x675.png)
![Immunoinformatic Analysis of Pancreatic Cancer Mutanomes: Impact of Regulatory T Cell Neo-Epitopes on Patient Outcome](https://epivax.com/wp-content/uploads/2019/05/EpiVax_Oncology_NYAS_08May19_35Wx25H-page-001-1080x675.jpg)
Immunoinformatic Analysis of Pancreatic Cancer Mutanomes: Impact of Regulatory T Cell Neo-Epitopes on Patient Outcome
EpiVax_Oncology_NYAS_08May19_35Wx25H![Ancer: An Innovative Cancer Neoantigen Prediction System](https://epivax.com/wp-content/uploads/2019/03/Ancer-An-Innovative-Cancer-Neoantigen-Prediction-System.jpg)
Ancer: An Innovative Cancer Neoantigen Prediction System
2017 Ancer An Innovative Cancer Neoantigen Prediction System![From infectious disease to personalized cancer vaccines: Regulatory T cell epitopes determine patient outcomes and suppress neoantigen responses](https://epivax.com/wp-content/uploads/2018/11/From-Infectious-Disease-to-Personalized-Cancer-Vaccines-Regulatory-T-Cell-Epitopes-Determine-Patient-Outcomes-and-Suppress-Neoantigen-Responses-1080x675.jpg)
From infectious disease to personalized cancer vaccines: Regulatory T cell epitopes determine patient outcomes and suppress neoantigen responses
EpiVax_Oncology_Ancer_SITC_05Nov18_39Wx35H![Disease Status Explained by Neo-epitopes with Low Potential for Activating Regulatory T cells: an Application of Precision Cancer Immunotherapy Design Tools to Bladder Cancer](https://epivax.com/wp-content/uploads/2018/10/Disease-Status-Explained-by-Neo-Epitopes-with-Low-Potential-for-Activating-Regulatory-T-Cells-1080x675.jpg)